Search - tctmd.com

Displaying 621 - 640 of 702

Sort: Relevancy | Date

News Conference News TCT 2014

Moderate-to-Severe AR After TAVR May Yield Greater Mortality Risk

September 13, 2014

News Conference News TCT 2013

TAVR a Viable Option for Intermediate-Risk Patients

November 05, 2013

News Conference News TCT 2013

TAVR, Surgical AVR Patients Show Similar Rates of Neurological Damage

November 03, 2013

Presentation TCT 2013

Second Prize: Case Presentation: Left Ventricular Pseudoaneurysm Closure after Transapical Transcatheter Aortic Valve Replacement

Presenter: Kazuaki Okuyama

November 01, 2013

Presentation TCT 2013

REPRISE II: A Prospective Registry Study of Transcatheter Aortic Valve Replacement with a Repositionable Transcatheter Heart Valve in Patients with Severe Aortic Stenosis

Presenter: Ian Meredith

October 31, 2013

Presentation TCT 2013

Histopathology of Embolic Debris Captured During Transcatheter Aortic Valve Replacement

Presenter: Nicolas van Mieghem

October 31, 2013

News Conference News TCT 2013

Two Trials to Assess TAVR in Moderate-Risk Patients

October 30, 2013

News Conference News TCT 2013

Memories of TCT 1988 and Beyond: Julio C. Palmaz, MD

October 30, 2013

Presentation TCT 2013

Transcatheter Aortic Valve Replacement: Assessment of the Learning Curve Based on the PARTNER Trial

Presenter: Oluseun Alli

October 29, 2013

Presentation TCT 2013

TCT-118. A Multidisciplinary, Multimodality, But Minimalist (3M) Approach To Transfemoral Transcatheter Aortic Valve Replacement Facilitates Safe Next Day Discharge In High Risk...

Presenter: David Wood

October 29, 2013

Presentation TCT 2013

TCT-120. Need for Permanent Pacemaker Following Implantation of the Repositionable Second-Generation LOTUS™ Device for Transcatheter Aortic Valve Replacement: Results From the...

Presenter: Nicolas Dumonteil

October 29, 2013

Presentation TCT 2013

TCT-114. Impact of Left Ventricular Function on Outcomes of Transcatheter Aortic Valve Replacement and Medical Therapy in Inoperable Patients with Aortic Stenosis: Insights from...

Presenter: Sammy Elmariah

October 29, 2013

Presentation TCT 2013

TCT-112. Left Ventricular Ejection Fraction Improves Less after Trans-Apical Transcatheter Aortic Valve Replacement Compared to a Trans-Femoral Approach

Presenter: William Fearon

October 29, 2013

Presentation TCT 2013

TCT-110. Lower risk of severe acute kidney injury in transcatheter aortic valve replacement: intracardiac echocardiography lowers radiocontrast medium requirements

Presenter: Thomas Bartel

October 29, 2013

Presentation TCT 2013

TCT-106. Novel Hemodynamic Index for the Assessment of Aortic Regurgitation After Transcatheter Aortic Valve Replacement

Presenter: Baris Bugan

October 29, 2013

Presentation TCT 2013

TAVI Karlsruhe (TAVIK) – a comparison of minimal invasive and surgical aortic valve replacement in patients with severe symptomatic aortic stenosis and intermediate risk for conventional surgery

Presenter: Gerhard Schymik

October 29, 2013

Presentation TCT 2013

COREVALVE EXTREME RISK: A Prospective Registry Study of Transcatheter Aortic Valve Replacement with a Self-Expanding Transcatheter Heart Valve in Patients with Severe Aortic...

Presenter: Jeffrey Popma

October 29, 2013

News Conference News TCT 2013

Opportunities Exist to Improve Outcomes in Transapical TAVR

October 29, 2013

Presentation TCT 2013

Mitral Regurgitation in Aortic Stenosis: How Often Is Surgical or Transcatheter Aortic Valve Replacement Effective?

Presenter: Howard Herrmann

October 28, 2013

Presentation TCT 2013

Transcatheter Based Aortic Valve Replacement using Tissue Engineered Heart Valves: Preclinical Experiences

Presenter: Simon Hoerstrup

October 28, 2013

Advertisement

Moderate-to-Severe AR After TAVR May Yield Greater Mortality Risk

TAVR a Viable Option for Intermediate-Risk Patients

TAVR, Surgical AVR Patients Show Similar Rates of Neurological Damage

Second Prize: Case Presentation: Left Ventricular Pseudoaneurysm Closure after Transapical Transcatheter Aortic Valve Replacement

REPRISE II: A Prospective Registry Study of Transcatheter Aortic Valve Replacement with a Repositionable Transcatheter Heart Valve in Patients with Severe Aortic Stenosis

Histopathology of Embolic Debris Captured During Transcatheter Aortic Valve Replacement

Two Trials to Assess TAVR in Moderate-Risk Patients

Memories of TCT 1988 and Beyond: Julio C. Palmaz, MD

Transcatheter Aortic Valve Replacement: Assessment of the Learning Curve Based on the PARTNER Trial

TCT-118. A Multidisciplinary, Multimodality, But Minimalist (3M) Approach To Transfemoral Transcatheter Aortic Valve Replacement Facilitates Safe Next Day Discharge In High Risk...

TCT-120. Need for Permanent Pacemaker Following Implantation of the Repositionable Second-Generation LOTUS™ Device for Transcatheter Aortic Valve Replacement: Results From the...

TCT-114. Impact of Left Ventricular Function on Outcomes of Transcatheter Aortic Valve Replacement and Medical Therapy in Inoperable Patients with Aortic Stenosis: Insights from...

TCT-112. Left Ventricular Ejection Fraction Improves Less after Trans-Apical Transcatheter Aortic Valve Replacement Compared to a Trans-Femoral Approach

TCT-110. Lower risk of severe acute kidney injury in transcatheter aortic valve replacement: intracardiac echocardiography lowers radiocontrast medium requirements

TCT-106. Novel Hemodynamic Index for the Assessment of Aortic Regurgitation After Transcatheter Aortic Valve Replacement

TAVI Karlsruhe (TAVIK) – a comparison of minimal invasive and surgical aortic valve replacement in patients with severe symptomatic aortic stenosis and intermediate risk for conventional surgery

COREVALVE EXTREME RISK: A Prospective Registry Study of Transcatheter Aortic Valve Replacement with a Self-Expanding Transcatheter Heart Valve in Patients with Severe Aortic...

Opportunities Exist to Improve Outcomes in Transapical TAVR

Mitral Regurgitation in Aortic Stenosis: How Often Is Surgical or Transcatheter Aortic Valve Replacement Effective?

Transcatheter Based Aortic Valve Replacement using Tissue Engineered Heart Valves: Preclinical Experiences

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content